Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,311 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Publisher Correction to: PET/MRI and PET/CT Radiomics in Primary Cervical Cancer: A Pilot Study on the Correlation of Pelvic PET, MRI, and CT Derived Image Features.
Esfahani SA, Torrado-Carvajal A, Amorim BJ, Groshar D, Domachevsky L, Bernstine H, Stein D, Gervais D, Catalano OA. Esfahani SA, et al. Among authors: stein d. Mol Imaging Biol. 2021 Nov 22. doi: 10.1007/s11307-021-01671-4. Online ahead of print. Mol Imaging Biol. 2021. PMID: 34811607 No abstract available.
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.
Peyrin-Biroulet L, Hart A, Bossuyt P, Long M, Allez M, Juillerat P, Armuzzi A, Loftus EV Jr, Ostad-Saffari E, Scalori A, Oh YS, Tole S, Chai A, Pulley J, Lacey S, Sandborn WJ; HICKORY Study Group. Peyrin-Biroulet L, et al. Lancet Gastroenterol Hepatol. 2021 Nov 16:S2468-1253(21)00298-3. doi: 10.1016/S2468-1253(21)00298-3. Online ahead of print. Lancet Gastroenterol Hepatol. 2021. PMID: 34798039
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
Vermeire S, Lakatos PL, Ritter T, Hanauer S, Bressler B, Khanna R, Isaacs K, Shah S, Kadva A, Tyrrell H, Oh YS, Tole S, Chai A, Pulley J, Eden C, Zhang W, Feagan BG; LAUREL Study Group. Vermeire S, et al. Lancet Gastroenterol Hepatol. 2021 Nov 16:S2468-1253(21)00295-8. doi: 10.1016/S2468-1253(21)00295-8. Online ahead of print. Lancet Gastroenterol Hepatol. 2021. PMID: 34798037
Perceived helpfulness of treatment for alcohol use disorders: Findings from the World Mental Health Surveys.
Degenhardt L, Bharat C, Chiu WT, Harris MG, Kazdin AE, Vigo DV, Sampson NA, Alonso J, Andrade LH, Bruffaerts R, Bunting B, Cardoso G, de Girolamo G, Florescu S, Gureje O, Haro JM, Hu C, Karam AN, Karam EG, Kovess-Masfety V, Lee S, Makanjuola V, McGrath JJ, Medina-Mora ME, Moskalewicz J, Navarro-Mateu F, Posada-Villa J, Rapsey C, Stagnaro JC, Tachimori H, Ten Have M, Torres Y, Williams DR, Zarkov Z, Kessler RC; WHO World Mental Health Survey collaborators, The WHO World Mental Health Survey collaborators are Sergio Aguilar-Gaxiola. Degenhardt L, et al. Drug Alcohol Depend. 2021 Nov 1;229(Pt B):109158. doi: 10.1016/j.drugalcdep.2021.109158. Online ahead of print. Drug Alcohol Depend. 2021. PMID: 34784556
3,311 results